Advertisement
Original Article|Articles in Press

OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema

Published:February 16, 2023DOI:https://doi.org/10.1016/j.jcjo.2023.01.012

      Abstract

      Purpose

      To evaluate disorganization of retinal inner layers (DRIL), as detected on spectral-domain optical coherence tomography (OCT) images, as a biomarker for diabetic macular edema (DME) activity, visual function, and prognosis in eyes with DME.

      Design

      Longitudinal prospective.

      Methods

      Post hoc correlation analyses were performed on data from a phase 2 clinical trial. Seventy-one eyes of 71 patients with treatment-naive DME received either suprachoroidally administered CLS-TA (proprietary formulation of a triamcinolone acetonide injectable suspension) combined with intravitreal aflibercept or intravitreal aflibercept with a sham suprachoroidal injection procedure. DRIL area, maximum horizontal extent of DRIL, ellipsoid zone (EZ) integrity, and the presence and location of subretinal (SRF) and intraretinal fluid (IRF) were evaluated at baseline and week 24 by certified reading centre graders.

      Results

      At baseline, the area and maximum horizontal extent of DRIL were negatively correlated with best-corrected visual acuity (BCVA; r = –0.25, p = 0.05 and r = –0.32, p =0.01, respectively). Mean baseline BCVA progressively worsened with each ordinal drop in EZ integrity, improved with the presence of SRF, and was invariant to the presence of IRF. DRIL area and maximum extent were significantly decreased at week 24 (–3.0 mm2 [p < 0.001] and –775.8 mm [p < 0.001], respectively. At week 24, decreases in the area and maximum horizontal extent of DRIL were positively correlated with increases in BCVA (r = –0.40, p = 0.003 and r = –0.30, p = 0.04). Improvements in BCVA at week 24 were no different between patients showing improvement in EZ, SRF, or IRF and those showing no improvement or worsening from baseline.

      Conclusions

      DRIL area and DRIL maximum horizontal extent were demonstrated to be novel biomarkers for macular edema status, visual function, and prognosis in eyes with treatment-naive DME.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nittala MG
        • Konduru R
        • Ruiz-Garcia H
        • Sadda SR.
        Effect of OCT volume scan density on thickness measurements in diabetic macular edema.
        Eye (Lond). 2011; 25: 1347-1355
        • Brown DM
        • Nguyen QD
        • Marcus DM
        • et al.
        Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
        Ophthalmology. 2013; 120: 2013-2022
        • Heier JS
        • Korobelnik JF
        • Brown DM
        • et al.
        Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies.
        Ophthalmology. 2016; 123: 2376-2385
        • Bressler SB
        • Ayala AR
        • Bressler NM
        • et al.
        Persistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairment.
        JAMA Ophthalmol. 2016; 134: 278-285
        • Gonzalez VH
        • Campbell J
        • Holekamp NM
        • et al.
        Early and long-term responses to anti–vascular endothelial growth factor therapy in diabetic macular edema: analysis of protocol I data.
        Am J Ophthalmol. 2016; 172: 72-79
        • Kiernan DF
        • Mieler WF
        • Hariprasad SM.
        Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems.
        Am J Ophthalmol. 2010; 149 (e2): 18-31
        • Comyn O
        • Heng LZ
        • Ikeji F
        • et al.
        Repeatability of Spectralis OCT measurements of macular thickness and volume in diabetic macular edema.
        Invest Ophthalmol Vis Sci. 2012; 53: 7754-7759
        • Ciulla TA
        • Kapik B
        • Grewal DS
        • Ip MS.
        Visual acuity in retinal vein occlusion, diabetic, and uveitic macular edema: central subfield thickness and ellipsoid zone analysis.
        Ophthalmol Retina. 2021; 5: 633-647
        • Browning DJ
        • Glassman AR
        • Diabetic Retinopathy Clinical Research Network
        Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema.
        Ophthalmology. 2007; 114: 525-536
        • Bressler NM
        • Odia I
        • Maguire M
        • et al.
        Association between change in visual acuity and change in central subfield thickness during treatment of diabetic macular edema in participants randomized to aflibercept, bevacizumab, or ranibizumab: a post hoc analysis of the protocol T randomized clinic.
        JAMA Ophthalmol. 2019; 137: 977-985
        • Radwan SH
        • Soliman AZ
        • Tokarev J
        • Zhang L
        • Van Kuijk FJ
        • Koozekanani DD.
        Association of disorganization of retinal inner layers with vision after resolution of center-involved diabetic macular edema.
        JAMA Ophthalmol. 2015; 133: 820-825
        • Sun JK
        • Lin MM
        • Lammer J
        • et al.
        Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
        JAMA Ophthalmol. 2014; 132: 1309-1316
        • Sun JK
        • Radwan SH
        • Soliman AZ
        • et al.
        Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema.
        Diabetes. 2015; 64: 2560-2570
        • Barakat MR
        • Wykoff CC
        • Gonzalez V
        • et al.
        Suprachoroidal CLS-TA plus intravitreal aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study.
        Ophthalmol Retina. 2021; 5: 60-70
        • Babiuch AS
        • Han M
        • Conti FF
        • Wai K
        • Silva FQ
        • Singh RP.
        Association of disorganization of retinal inner layers with visual acuity response to anti–vascular endothelial growth factor therapy for macular edema secondary to retinal vein occlusion.
        JAMA Ophthalmol. 2019; 137: 38-46
        • Sadda SR
        • Joeres S
        • Wu Z
        • et al.
        Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading.
        Invest Ophthalmol Vis Sci. 2007; 48: 839-848
        • Pappuru RR
        • Ouyang Y
        • Nittala MG
        • et al.
        Relationship between outer retinal thickness substructures and visual acuity in eyes with dry age-related macular degeneration.
        Invest Ophthalmol Vis Sci. 2011; 52: 6743-6748
        • Joltikov KA
        • Sesi CA
        • de Castro VM
        • et al.
        Disorganization of retinal inner layers (DRIL) and neuroretinal dysfunction in early diabetic retinopathy.
        Invest Ophthalmol Vis Sci. 2018; 59: 5481-5486
        • Das R
        • Spence G
        • Hogg RE
        • Stevenson M
        • Chakravarthy U.
        Disorganization of inner retina and outer retinal morphology in diabetic macular edema.
        JAMA Ophthalmol. 2018; 136: 202-208
        • Zur D
        • Iglicki M
        • Sala-Puigdollers A
        • et al.
        Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
        Acta Ophthalmol. 2020; 98: e217-e223
        • Wirth MA
        • Wons J
        • Freiberg FJ
        • Becker MD
        • Michels S.
        Impact of long-term intravitreal anti–vascular endothelial growth factor on preexisting microstructural alterations in diabetic macular edema.
        Retina. 2018; 38: 1824-1829
        • Pelosini L
        • Hull CC
        • Boyce JF
        • McHugh D
        • Stanford MR
        • Marshall J.
        Optical coherence tomography may be used to predict visual acuity in patients with macular edema.
        Invest Ophthalmol Vis Sci. 2011; 52: 2741-2748
        • Nicholson L
        • Ramu J
        • Triantafyllopoulou I
        • et al.
        Diagnostic accuracy of disorganization of the retinal inner layers in detecting macular capillary non-perfusion in diabetic retinopathy.
        Clin Exp Ophthalmol. 2015; 43: 735-741
        • Dodo Y
        • Murakami T
        • Suzuma K
        • et al.
        Diabetic neuroglial changes in the superficial and deep nonperfused areas on optical coherence tomography angiography.
        Invest Ophthalmol Vis Sci. 2017; 58: 5870-5879
        • Moein HR
        • Novais EA
        • Rebhun CB
        • et al.
        Optical coherence tomography angiography to detect macular capillary ischemia in patients with inner retinal changes after resolved diabetic macular edema.
        Retina. 2018; 38: 2277-2284
        • Onishi AC
        • Ashraf M
        • Soetikno BT
        • Fawzi AA.
        Multilevel ischemia in disorganization of the retinal inner layers on projection-resolved optical coherence tomography angiography.
        Retina. 2019; 39: 1588-1594
        • Sampani K
        • Abdulaal M
        • Peiris T
        • et al.
        Comparison of SDOCT scan types for grading disorganization of retinal inner layers and other morphologic features of diabetic macular edema.
        Transl Vis Sci Technol. 2020; 9: 1-9